Abstracts

Does the Availability of New DAAs Influence Treatment Uptake in Acute Hepatitis C in HIV Coinfection?

Background: With the availability of newer DAAs for treatment of chronic hepatitis C infection (HCV) HCV therapy has become considerably less toxic and even more successful than treatment of acute hepatitis C infection (AHC) with pegylated interferon (pegIFN) and ribavirin (RBV). Current DAA-based regimens are not approved for treatment of AHC and thus, also not…

Long-Term Follow-Up of HIV-Positive Men Who Have Sex With Men (MSM) With Acute Hepatitis C Virus (HCV) Infection: High Rates of Treatment and Low Rates of Liver-Related Complications

Background: Acute hepatitis C has been identified as a major factor of morbidity in HIV-infected MSM. Interferon-based treatments have been extensively used in this population in Europe. However, benefits related to treatment remain unknown in this population, bringing into question the use of interferon in the era of directly acting antivirals. Methods: Retrospective analysis of…

Hepatitis C in Men Who Have Sex with Men With New HIV Diagnoses in Los Angeles

Background: Geographic and sociodemographic characterization of hepatitis C virus (HCV) transmission amongst men who have sex with men (MSM) has been limited. Our aim was to characterize HCV prevalence, risk factors for HCV co-infection, and patterns of HIV and HCV co-transmission and transmitted drug resistance mutations (DRMs) in newly HIV-diagnosed Los Angeles MSM. Methods: We…

Development and Comparison of Hepatitis C Cross-Sectional Incidence Testing Methods

Background: The traditional method to determine hepatitis C (HCV) incidence requires longitudinal cohorts. However, cohort studies are challenging because they are expensive, time consuming, and may not achieve sufficient follow-up in high-risk populations such as people who inject drugs (PWIDs). The ability to detect recently infected individuals from a cross-sectional survey would reduce the need…

Behavioural and Treatment Interventions to Reduce HCV Transmissions in HIV+ MSM

Background: The incidence of hepatitis C virus (HCV) infections among HIV-infected men who have sex with men (MSM) increased markedly in industrialized countries and is associated with high risk sexual behaviour including traumatic sex. Finding the most effective interventions to control this epidemic is key to reducing liver-related morbidity and mortality in these patients. HCV…

Macrophage Activation and Hepatitis C (HCV) Disease Progression in HIV-Infected Women Participating in the Women’s Interagency HIV Study (WIHS)

Background: Hepatic macrophage activation by endotoxin is thought to contribute to hepatic fibrosis in HCV infection. We measured changes in markers of macrophage activation, microbial translocation and inflammation in HIV/HCV co-infected women comparing women who had rapid liver disease progression to liver disease non-progressors. Methods: Soluble CD163 and CD14, lipopolysaccharide (LPS), tumor necrosis factor receptor…

HIV/HCV Co-Infection Accelerated Liver Disease is Associated With Induction of M2-Like Macrophages

Background: Chronic hepatitis B/C virus-induced liver diseases including fibrosis and cancer are exacerbated by human immunodeficiency virus (HIV) co-infection. Furthermore, HCV and HIV co-infection is a major cause of mortality in HIV-infected patients in western countries. The underlying pathogenic mechanisms by which chronic hepatitis viruses and HIV-1 co-infection induce and exacerbate liver diseases respectively remain…